StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.85+0.12 (+2.54%)

Close on Nov 18, 2026Market cap $343.33MP/E –Yield –

YD Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$5.27M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.27M–
FY2024Dec 31, 2024-$1.46M–
FY2023Dec 31, 2023-$9.85K–

More YD Bio figures

See a number that looks wrong?